TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive NCAB Ponders Patient Accrual Problems, Members Irate Over System That Discourages Participation February 19, 1988
TCL Archive CCIRC Okays New Effort To Rate Disease Committees, Modalities In Groups, Effective with Next Round November 20, 1981
TCL Archive ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer October 9, 2009